1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Prostrate Specific Antigen (PSA) Testing Market Analysis: By Type (Free PSA Test, Complex PSA Test, Reverse PCR Test); By Geography (North America, Europe, APAC) - Forecast (2015 – 2020)

Prostrate Specific Antigen is secreted by epithelial prostatic cells. The primary function of PSA is to break down high molecular weight protein of the seminal coagulum into smaller polypeptides. The PSA is present in serum which is used to detect prostate cancer. There is a continuous circulation of PSA in the blood.

The PSA testing is gaining popularity among clinicians and hospitals as the number of people affected by prostate cancer in the age bracket of 40-50 years is on a rise. A high level of PSA is an indicator of possible prostate cancer. However, there are other physical conditions which might lead to an increase in PSA levels.

The number of people affected by prostate cancer in 2014 was 233,000 from 417,000 in 2012. The reason for this sharp decline in prostate cancer incidences is due to effective PSA testing. The global PSA testing market was close to $250 million in 2014. The population in the age bracket of 50-64 years are more likely to develop prostate cancer. Prostate Cancer is the fourth most common cancer. The need for PSA testing has seen an upward surge. The North America region is going to see the highest increase due to better focus on healthcare. The Europe region has different guidelines and policies for PSA testing in different countries. Such scenario has led to a decreased use of PSA testing in Europe region.

Market size and forecast is provided for each of these regions. A detailed qualitative analysis of the factors responsible for driving and restraining growth of the PSA testing market and future opportunities are provided in the report. This report on the global PSA testing market identifies many such insights and M&A opportunities, besides providing a detailed analysis of the PSA testing market.

Table Of Contents

Prostrate Specific Antigen (PSA) Testing Market Analysis: By Type (Free PSA Test, Complex PSA Test, Reverse PCR Test); By Geography (North America, Europe, APAC) - Forecast (2015 - 2020)
1. PSA Testing Market Overview

2. Executive Summary

3. PSA Testing Market Landscape

3.1. Market Share Analysis

3.2. Comparative Analysis

3.2.1. Product Benchmarking

3.2.2. End user profiling

3.2.3. Patent Analysis

3.2.4. Top 5 Financials Analysis



4. PSA Testing Market Forces

4.1. Market Drivers

4.2. Market Constraints

4.3. Market Challenges

4.4. Attractiveness of the Industry

4.4.1. Power of Suppliers

4.4.2. Power of Customers

4.4.3. Threat of New entrants

4.4.4. Threat of Substitution

4.4.5. Degree of Competition

5. PSA Testing Market - Strategic Analysis

5.1. Value Chain Analysis

5.2. Opportunities Analysis

5.3. Product/Market Life Cycle Analysis

6. PSA Testing Market - By Type

6.1. Free Prostate Speficic Antigen Test

6.2. Complex Prostate Specific Antigen Test

6.3. Prostate Specific Antigen Reverse Transcription Polymerase Chain Reaction Test

7. Global PSA Testing Market - Geographic Analysis

7.1. Introduction

7.2. North America

7.2.1. Canada

7.2.2. USA

7.3. Europe

7.4. APAC

7.5. ROW

8. Market Entropy

8.1. New Product Launches

8.2. MandAs, Collaborations, JVs and Partnerships

9. Company Profiles (Overview, Financials, SWOT Analysis - Top 5 Companies, Developments, Product Portfolio)

9.1. Abbott Laboratories, Inc.

9.2. Bayer AG

9.3. Beckman Coulter, Inc.

9.4. GE Helathcare

9.5. GlaxoSmithKline, plc.

9.6. Novartis Pharma AG.

9.7. UroLogix, Inc.

9.8. Bristol - Myers Squibb Company

9.9. AstraZeneca plc.

9.10. Johnson and Johnson Diagnostics

9.11. BioChem Pharma

9.12. Pharmacia Delfia

9.13. Roche Diagnostics

9.14. Olympus

9.15. Tosho

"*Financials would be provided on a best efforts basis for private companies"

10. Appendix

10.1. Abbreviations

10.2. Sources

10.3. Research Methodology

10.4. Bibliography

10.5. Compilation of Expert Insights

10.6. Disclaimer

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Hematological Cancers: Analytical Tool

Hematological Cancers: Analytical Tool

  • $ 11505
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation

  • $ 6995
  • Industry report
  • September 2016
  • by GBI Research

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation Summary Glioblastoma multiforme (GBM) is a grade IV tumor that arises from astrocytes. It is ...

Drugs and Diagnostics for Hematological Disorders: Global Markets

Drugs and Diagnostics for Hematological Disorders: Global Markets

  • $ 6650
  • Industry report
  • September 2016
  • by BCC Research

Use this report to: - Receive detailed information regarding screening, testing and treatment options for hematological disorders and blood cancer. - Learn about the types of diagnostic and treatment ...

Lung Cancer: Analytical Tool

August 2016 $ 8096

Ovarian Cancer: Analytical Tool

August 2016 $ 8096

Renal Cancer: Analytical Tool

August 2016 $ 8096

Bladder Cancer: Analytical Tool

August 2016 $ 8096

Download Unlimited Documents from Trusted Public Sources

Breast Cancer Statistics in Africa

  • December 2016
    14 pages
  • Breast Cancer  

  • Africa  

View report >

Therapy and Hormone Market in South Korea

  • December 2016
    4 pages
  • Therapy  

    Hormone  

    Cancer  

  • South Korea  

View report >

Cancer Statistics in the UK

  • December 2016
    20 pages
  • Cancer  

  • United Kingdom  

    Europe  

View report >

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.